129 related articles for article (PubMed ID: 27084847)
1. The TLR7 agonist imiquimod induces bronchodilation via a nonneuronal TLR7-independent mechanism: a possible role for quinoline in airway dilation.
Larsson OJ; Manson ML; Starkhammar M; Fuchs B; Adner M; Kumlien Georén S; Cardell LO
Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1121-9. PubMed ID: 27084847
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs.
Kaufman EH; Fryer AD; Jacoby DB
J Allergy Clin Immunol; 2011 Feb; 127(2):462-9. PubMed ID: 21167577
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 7 rapidly relaxes human airways.
Drake MG; Scott GD; Proskocil BJ; Fryer AD; Jacoby DB; Kaufman EH
Am J Respir Crit Care Med; 2013 Sep; 188(6):664-72. PubMed ID: 23924358
[TBL] [Abstract][Full Text] [Related]
4. Imiquimod induces a Toll-like receptor 7-independent increase in intracellular calcium via IP(3) receptor activation.
Hwang H; Min H; Kim D; Yu SW; Jung SJ; Choi SY; Lee SJ
Biochem Biophys Res Commun; 2014 Jul; 450(1):875-9. PubMed ID: 24971541
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod induces ER stress and Ca(2+) influx independently of TLR7 and TLR8.
Nyberg WA; Espinosa A
Biochem Biophys Res Commun; 2016 May; 473(4):789-794. PubMed ID: 27003259
[TBL] [Abstract][Full Text] [Related]
6. Bitter tasting compounds dilate airways by inhibiting airway smooth muscle calcium oscillations and calcium sensitivity.
Tan X; Sanderson MJ
Br J Pharmacol; 2014 Feb; 171(3):646-62. PubMed ID: 24117140
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of Toll-like receptor 7 stimulation in asthma.
Drake MG; Kaufman EH; Fryer AD; Jacoby DB
Inflamm Allergy Drug Targets; 2012 Dec; 11(6):484-91. PubMed ID: 23078048
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR
Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675
[TBL] [Abstract][Full Text] [Related]
9. [Expression of Toll-like receptor 7 in gastric cancer cell lines and effects of TLR7 agonist on proliferation and apoptosis of SGC-7901 cells in vitro].
Jiang J; Dong L; Qin B; Guo X; Li H; Shi H; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1606-10. PubMed ID: 25413058
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.
Van Ly D; De Pedro M; James P; Morgan L; Black JL; Burgess JK; Oliver BG
Respir Res; 2013 Nov; 14(1):127. PubMed ID: 24237854
[TBL] [Abstract][Full Text] [Related]
11. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion.
Schön MP; Schön M; Klotz KN
J Invest Dermatol; 2006 Jun; 126(6):1338-47. PubMed ID: 16575388
[TBL] [Abstract][Full Text] [Related]
12. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways.
Duechs MJ; Hahn C; Benediktus E; Werner-Klein M; Braun A; Hoymann HG; Gantner F; Erb KJ
Pulm Pharmacol Ther; 2011 Apr; 24(2):203-14. PubMed ID: 21195789
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 agonists and skin.
Novak N; Yu CF; Bieber T; Allam JP
Drug News Perspect; 2008 Apr; 21(3):158-65. PubMed ID: 18560614
[TBL] [Abstract][Full Text] [Related]
14. Antimitogenic effect of bitter taste receptor agonists on airway smooth muscle cells.
Sharma P; Panebra A; Pera T; Tiegs BC; Hershfeld A; Kenyon LC; Deshpande DA
Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(4):L365-76. PubMed ID: 26684251
[TBL] [Abstract][Full Text] [Related]
15. A dual and conflicting role for imiquimod in inflammation: A TLR7 agonist and a cAMP phosphodiesterase inhibitor.
Ernst O; Failayev H; Athamna M; He H; Tsfadia Y; Zor T
Biochem Pharmacol; 2020 Dec; 182():114206. PubMed ID: 32828805
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
Ahn MY; Kwon SM; Cheong HH; Park JH; Lee J; Min SK; Ahn SG; Yoon JH
J Oral Pathol Med; 2012 Aug; 41(7):540-6. PubMed ID: 22577802
[TBL] [Abstract][Full Text] [Related]
17. The antiviral activity of Toll-like receptor 7 and 7/8 agonists.
Miller RL; Meng TC; Tomai MA
Drug News Perspect; 2008 Mar; 21(2):69-87. PubMed ID: 18389099
[TBL] [Abstract][Full Text] [Related]
18. TLR7 agonist attenuates acetylcholine-induced, Ca
Gamo S; Tamada T; Murakami K; Muramatsu S; Aritake H; Nara M; Kazama I; Okazaki T; Sugiura H; Ichinose M
Exp Physiol; 2018 Nov; 103(11):1543-1559. PubMed ID: 30194882
[TBL] [Abstract][Full Text] [Related]
19. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
[TBL] [Abstract][Full Text] [Related]
20. TLR7 in channel catfish (Ictalurus punctatus) is expressed in the endolysosome and is stimulated by synthetic ssRNA analogs, imiquimod, and resiquimod.
Felch KL; Crider JD; Bhattacharjee D; Huhn C; Wilson M; Bengtén E
Dev Comp Immunol; 2024 Aug; 157():105197. PubMed ID: 38763479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
